SoftServe Appoints Alex Chubay as Chief Technology Officer
Feb 22, 2018 12:00 pm UTC| Business
AUSTIN, Texas, Feb. 22, 2018 -- SoftServe, a leading global digital authority and consulting company, today announces its appointment of Alex Chubay as Chief Technology Officer, effective immediately. Chubay will lead...
Feb 22, 2018 12:00 pm UTC| Business
NASHVILLE, Tenn., Feb. 22, 2018 -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its fourth quarter...
Harsco Corporation Reports Fourth Quarter and Full-Year 2017 Results
Feb 22, 2018 11:59 am UTC| Business
Q4 GAAP Operating Income of $38 Million; Each Business Segment Contributed to Results That Exceeded Guidance Range Q4 Revenues Increased 26 Percent Compared with the Prior-Year Quarter Net Cash Provided by Operating...
Revenues from the Transit Packaging Market are poised to surpass US$ 200,000 Mn by 2026-End
Feb 22, 2018 11:59 am UTC| Business
VALLEY COTTAGE, NY, Feb. 22, 2018 -- Published On: A new research report of Future Market Insights has slated an above-average expansion for the global transit packaging market through the forecast period (2017-2026)....
Ameri100 Secures Digital Transformation Win With SAP S/4HANA Private Cloud Deployment
Feb 22, 2018 11:59 am UTC| Business
PRINCETON, N.J., Feb. 22, 2018 -- AMERI Holdings, Inc. (NASDAQ:AMRH) (“Ameri100”), a specialized SAP® cloud, digital and enterprise services company, today announced that it has been awarded a digital transformation...
Visteon Reports Strong 2017 Financial Results
Feb 22, 2018 11:55 am UTC| Business
Delivered strong financial performance Sales of $3,146 million ($797 million in fourth quarter)Net income of $176 million ($25 million in fourth quarter)Adjusted EBITDA of $370 million ($102 million in fourth quarter)Net...
Loxo Oncology to Announce Fourth Quarter and Year-End 2017 Financial Results
Feb 22, 2018 11:45 am UTC| Business
STAMFORD, Conn., Feb. 22, 2018 -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, will announce...